Association between the occurrence of adenomyosis and the clinical outcomes of vaginal repair of cesarean section scar defects: an observational study

Table 2 Clinical outcomes after treatment for cesarean scar defect

Variable	Adenomyosis group (n = 50)	Non-adenomyosis group (n = 228)	P value
Hemoglobin on the first postoperative day (g/L)	99.5 ± 13.4 (74.2–125.0)	106.0 ± 11.2 (77.2–134.0)	0.012
Blood loss during operation (ml)	31.8 ± 20.0 (10–100)	30.8 ± 23.6 (10–200)	0.745
Duration of surgical procedure (min)	57.0 ± 11.8 (30–90)	55.9 ± 9.4 (25–99)	0.497
Length of hospital stay (d)	7.0 (1.0)	6.5 (1.0)	0.296^**
Hospitalization cost (CNY)	10,870 (2175.3)	11,085.0(1997.3)	0.528^**
Complications (n)
Bladder injury	0 (0.0%)	2 (.9%)	0.672*
Hematoma	1 (2.0%)	2 (.9%)	0.450*

Data presented as mean ± SD (range) except for complications, length of hospital stay and hospitalization cost, where complications presented as numbers (percentage) and length of hospital stay and hospitalization cost presented as median (interquartile range)
* Fisher’s Exact Test was used. ^** Mann-Whitney U Test was used

ISSN: 1471-2393